Peripheral neuropathy associated with ipilimumab: a report of 2 cases.

@article{Thaipisuttikul2015PeripheralNA,
  title={Peripheral neuropathy associated with ipilimumab: a report of 2 cases.},
  author={Iyavut Thaipisuttikul and Paul B Chapman and Edward K. Avila},
  journal={Journal of immunotherapy},
  year={2015},
  volume={38 2},
  pages={77-9}
}
Ipilimumab, a monoclonal antibody targeting human cytotoxic T-lymphocyte-associated antigen 4, was approved by the FDA and European Medicines Agency for the treatment of metastatic melanoma. Immune-related adverse effects can occur with the use of this agent, but peripheral nervous system problems are rare. We report 2 cases of ipilimumab-induced polyneuropathy. 
9 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…